Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Conditions: Mortality in Sickle Cell; Sickle Cell Cardiopulmonary Complications; Sickle Cell Organ Damage; Sickle Cell Life Expectancy and Risk Factors for Early Death; Sickle Cell Lung Disease and Sudden Death Intervention: Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials